ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Atrimed Pharmaceuticals Plant Science receives breakthrough in molecule research for COVID-19 cure by ICMR approved regional centre for biotechnology

Bengaluru (Karnataka) [India], Aug 14 (ANI/NewsVoir): Bangalore based Atrimed Pharmaceuticals, a pioneer in developing scientifically tested Plant based medication, announced that, three of our samples tested positive against SARS-CoV-2 in the ICMR (Indian Council for Medical Research) designated laboratory and the developed drug will be available as an Oral medicine.

ANI Aug 14, 2020 18:23 IST googleads

Dr Hrishikesh Damle MD & CEO, Atrimed Pharmaceuticals

Bengaluru (Karnataka) [India], Aug 14 (ANI/NewsVoir): Bangalore based Atrimed Pharmaceuticals, a pioneer in developing scientifically tested Plant based medication, announced that, three of our samples tested positive against SARS-CoV-2 in the ICMR (Indian Council for Medical Research) designated laboratory and the developed drug will be available as an Oral medicine.
Company Leverages Proven Antiviral and Plant based medicinal expertise to evaluate the new approaches for treating the Novel Coronavirus Disease COVID-19. Atrimed Pharma is dedicated to develop a phytomolecule drugs for viral infections and other diseases, today takes pride that it has initiated a program to discover drug candidates for the treatment of patients infected with the novel coronavirus COVID-19, also known as SARS-CoV-2.
"Based on our proven track record in virology and our capabilities in rare diseases, we believe our core competencies position us well to discover a potential treatment for COVID-19, and we are delighted to establish that three molecules out of ten submitted are passed the test and ready for Human/Clinical Trial for developing drug for the treatment of Coronavirus," stated Dr Hrishikesh Damle MD & CEO, while commenting on the exclusive breakthrough.
He further added that these molecules were ready for scientific research in the month of March 2020 itself but took so long for clearance. "Our decision to initiate a drug discovery for COVID-19 is a natural evolution of our work and mission. Regional Centre for Biotechnology has recognised and approved 3 effective plant molecules against COVID-19 and further studies will begin shortly."
The Drug Discovery and Development Process passes through various stages which begins with Target Selection leading to discovery where in high throughput screening paves for chemical synthesis and then prepares for Vitro/Behavioural Studies and finally for Clinical/Human trial, and it is great achievement for Atrimed to take their research to their drug development to the next level.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Get the App

What to Read Next

Business

Sarbabharatiya Sangeet O Sanskriti Parishad Convenes 48th Annual

Sarbabharatiya Sangeet O Sanskriti Parishad Convenes 48th Annual

Kolkata (West Bengal) [India], March 12: Sarbabharatiya Sangeet O Sanskriti Parishad officially commenced its 48th Annual Convocation yesterday, March 11, at the historic Mahajati Sadan, Kolkata. The three-day event, running from March 11 to 13, celebrates the institution's legacy of cultural service and its mission to bridge traditional heritage with a modernized future.

Read More
Business

PM Narendra Modi To Headline NXT Summit 2026 Today

PM Narendra Modi To Headline NXT Summit 2026 Today

New Delhi [India], March 12: Prime Minister Narendra Modi will headline the NXT Summit 2026 in New Delhi today, March 12. PM Modi will inaugurate the Bharat Progress Report and deliver the chief guest's address at the three-day global leadership forum.

Read More
Business

Lexlegis to Showcase AI-Driven Legal-Tech Solutions at NVIDIA

Lexlegis to Showcase AI-Driven Legal-Tech Solutions at NVIDIA

Mumbai (Maharashtra) [India], March 12: Lexlegis, a pioneering legal-tech and AI-driven compliance solutions company, will participate in the prestigious NVIDIA GTC (GPU Technology Conference), scheduled to take place from March 16 to March 19, 2026, in San Jose. The company will exhibit its latest innovations at Booth #4054, engaging with global technology leaders, developers, and enterprises exploring the transformative power of artificial intelligence.

Read More
Business

IVCA Alternate Capital Excellence Awards 2026

IVCA Alternate Capital Excellence Awards 2026

Mumbai (Maharashtra) [India], March 12: The IVCA Alternate Capital Excellence Awards 2026 were presented at the 15th edition of the IVCA Conclave, organised by India's apex body for the alternate capital sector, the Indian Venture and Alternate Capital Association (IVCA). Held on Day 2 of the Conclave, the Awards honoured the institutions and individuals exemplifying excellence in performance, governance, and creating enduring value across the alternate asset ecosystem, spanning private equity, venture capital, private credit, venture debt, real estate, infrastructure, and impact investing.

Read More
Business

Dr. Rasha Kelej Recognized Among the "100 Most Impactful Voices"

Dr. Rasha Kelej Recognized Among the

Accra [Ghana] / Mumbai (Maharashtra) [India], March 12: Dr. Rasha Kelej, CEO of Merck Foundation, has been recognized among the "100 Most Impactful Voices 2026" by ABCD Africa, a prestigious recognition celebrating influential women of African descent who are using their platforms to inspire change, amplify important social conversations, and drive meaningful impact across communities. The list features prominent women leaders and changemakers from 54 African countries and also includes the President of Tanzania. The list came out on the occasion of International Women's Day 2026.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.